...
首页> 外文期刊>The Journal of rheumatology >The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.
【24h】

The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.

机译:在已确立的绝经后骨质疏松症中,椎骨和非椎骨脆性骨折对健康相关生活质量的影响:绝经后妇女特立帕肽随机,安慰剂对照试验的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To report the combined impact of both vertebral and non-vertebral fractures on decreased health-related quality of life (HRQOL) in postmenopausal women (mean age 70.7) with osteoporosis who participated in a clinical trial to examine the anti-fracture efficacy of teriparatide [rhPTH(1-34)] injection. METHODS: Patients were randomly assigned to 1 of 3 study arms: placebo, 20 micro g or 40 micro g of teriparatide by daily self-injection. All patients received daily calcium (1000 mg) and vitamin D (400-1200 U) supplements. Patients were followed for a median of 21 months. Incident vertebral fractures were assessed by lateral spinal radiograph. Incident non-vertebral fractures were ascertained by patient self-report and verified by a review of radiological reports. HRQOL was assessed at baseline and annually until study termination using the Osteoporosis Assessment Questionnaire (OPAQ), a validated disease-targeted instrument. RESULTS: Of the 365 women in the HRQOL sub-study, 53 had an incident vertebral or non-vertebral fracture during the study period. Compared to women without incident fractures, women who fractured reported significant declines in physical functioning, emotional status, and symptoms (all p < 0.05). Similarly, when analysis was limited to patients with significant loss in HRQOL, patients with incident fracture accounted for a greater proportion of those patients with decreased physical function, emotional status, and increased symptoms (all p < 0.05). CONCLUSION: Our results confirm and extend previous findings to show that a composite endpoint of incident vertebral and non-vertebral fractures in women with postmenopausal osteoporosis was associated with significant decreases in HRQOL.
机译:目的:报告椎骨和非椎骨骨折对绝经后骨质疏松妇女(平均年龄70.7)的健康相关生活质量(HRQOL)下降的综合影响,这些妇女参加了一项临床试验,研究了该药的抗骨折功效特立帕肽[rhPTH(1-34)]注射剂。方法:通过每日自我注射,将患者随机分配至3个研究组中的1个:安慰剂,20微克或40微克的特立帕肽。所有患者每日接受钙(1000毫克)和维生素D(400-1200 U)补充。随访患者中位时间为21个月。通过脊柱侧位X线片评估椎体骨折的发生率。通过患者的自我报告确定非椎骨骨折的发生,并通过回顾放射学报告进行核实。 HRQOL在基线和每年进行评估,直到使用骨质疏松评估问卷(OPAQ)(一种经过验证的针对疾病的仪器)终止研究为止。结果:在HRQOL子研究中的365名妇女中,有53名在研究期间发生了脊椎或非脊椎骨折。与未发生骨折的女性相比,骨折的女性报告其身体机能,情绪状态和症状明显下降(所有p <0.05)。同样,当分析仅限于HRQOL明显降低的患者时,发生骨折的患者在那些身体功能下降,情绪状态和症状增加的患者中所占比例更大(所有p <0.05)。结论:我们的结果证实并扩展了先前的研究结果,表明绝经后骨质疏松妇女的椎骨和非椎体骨折的复合终点与HRQOL显着降低有关。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号